CAD 7.15
(1.85%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.32 Billion USD | -10.25% |
2022 | 1.47 Billion USD | 16.45% |
2021 | 1.26 Billion USD | 243.15% |
2020 | 368.2 Million USD | 19.34% |
2019 | 308.53 Million USD | 433.31% |
2018 | 57.85 Million CAD | 15578.7% |
2017 | 368.99 Thousand CAD | 11.38% |
2016 | 331.3 Thousand CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 1.42 Billion USD | 8.17% |
2024 Q2 | 1.48 Billion USD | 4.22% |
2023 FY | 1.32 Billion USD | -10.25% |
2023 Q2 | 1.34 Billion USD | -7.15% |
2023 Q4 | 1.32 Billion USD | -1.05% |
2023 Q1 | 1.45 Billion USD | -1.42% |
2023 Q3 | 1.33 Billion USD | -0.91% |
2022 Q4 | 1.47 Billion USD | 12.31% |
2022 FY | 1.47 Billion USD | 16.45% |
2022 Q1 | 1.4 Billion USD | 11.33% |
2022 Q2 | 1.34 Billion USD | -4.44% |
2022 Q3 | 1.31 Billion USD | -2.54% |
2021 Q1 | 411.87 Million USD | 11.86% |
2021 FY | 1.26 Billion USD | 243.15% |
2021 Q4 | 1.26 Billion USD | 178.67% |
2021 Q3 | 453.39 Million USD | 16.23% |
2021 Q2 | 390.07 Million USD | -5.29% |
2020 FY | 368.2 Million USD | 19.34% |
2020 Q4 | 368.2 Million USD | -3.52% |
2020 Q3 | 381.62 Million USD | -0.0% |
2020 Q2 | 381.63 Million USD | 11.4% |
2020 Q1 | 342.56 Million USD | 11.03% |
2019 Q2 | 197.03 Million USD | 92.06% |
2019 Q4 | 308.53 Million USD | 50.27% |
2019 Q3 | 205.32 Million USD | 4.21% |
2019 Q1 | 102.58 Million CAD | 77.32% |
2019 FY | 308.53 Million USD | 433.31% |
2018 Q2 | 390.82 Thousand CAD | 6.04% |
2018 Q4 | 57.85 Million CAD | 20.27% |
2018 FY | 57.85 Million CAD | 15578.7% |
2018 Q1 | 368.56 Thousand CAD | -0.12% |
2018 Q3 | 48.1 Million CAD | 12208.42% |
2017 Q4 | 368.99 Thousand CAD | -2.24% |
2017 Q1 | - USD | -100.0% |
2017 Q3 | 377.44 Thousand CAD | 0.0% |
2017 FY | 368.99 Thousand CAD | 11.38% |
2016 Q4 | 331.3 Thousand CAD | 0.0% |
2016 FY | 331.3 Thousand CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aion Therapeutic Inc. | 2.93 Million CAD | -44866.555% |
Ayurcann Holdings Corp. | 14.31 Million CAD | -9121.606% |
Blueberries Medical Corp. | 470.72 Thousand CAD | -280413.593% |
The BC Bud Corporation | 626 Thousand CAD | -210831.879% |
BioNxt Solutions Inc. | 6.55 Million CAD | -20058.746% |
CordovaCann Corp. | 11.29 Million CAD | -11594.716% |
Christina Lake Cannabis Corp. | 8.5 Million CAD | -15432.768% |
Captor Capital Corp. | 28.76 Million CAD | -4490.52% |
City View Green Holdings Inc. | 3.73 Million CAD | -35272.396% |
1CM Inc. | 9.42 Million CAD | -13911.953% |
Global Hemp Group Inc. | 5.82 Million CAD | -22567.972% |
Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | -6136.126% |
IM Cannabis Corp. | 35.11 Million CAD | -3660.55% |
Lobe Sciences Ltd. | 2.45 Million CAD | -53584.84% |
Maple Leaf Green World Inc. | 10.08 Million CAD | -12998.391% |
Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -511699.225% |
Nextleaf Solutions Ltd. | 4.4 Million CAD | -29887.187% |
Ovation Science Inc. | 728.99 Thousand CAD | -181032.578% |
Pharmadrug Inc. | 2.92 Million CAD | -45036.064% |
Captiva Verde Wellness Corp. | 2.08 Million CAD | -63110.648% |
RAMM Pharma Corp. | 2.83 Million CAD | -46468.044% |
RIV Capital Inc. | 275.63 Million CAD | -379.05% |
Revive Therapeutics Ltd. | 3.4 Million CAD | -38691.645% |
Red White & Bloom Brands Inc. | 364.63 Million CAD | -262.123% |
SLANG Worldwide Inc. | 37.58 Million CAD | -3413.43% |
1933 Industries Inc. | 23.28 Million CAD | -5571.3% |
Red Light Holland Corp. | 3.82 Million CAD | -34451.548% |
Top Strike Resources Corp. | 20.99 Million CAD | -6189.617% |
Xebra Brands Ltd. | 789.95 Thousand CAD | -167054.078% |
Adastra Holdings Ltd. | 17.65 Million CAD | -7378.028% |